| Literature DB >> 32475436 |
Joanna Kowalczyk1, Marcin Śmiałek2, Bartłomiej Tykałowski2, Daria Dziewulska2, Tomasz Stenzel2, Andrzej Koncicki2.
Abstract
Considering the lack of research on the local immunity of the reproductive tract in other poultry species than chickens, the aim of this study was to determine the contribution of T and B cell subpopulations in different parts of breeder turkey oviduct mucous membrane with the use of flow cytometry. In addition, the study aimed to establish an impact of bird age and different stages of the egg production cycle on the systemic and local oviduct-related immune system structure. Our study results demonstrated a lower percentage of T lymphocytes in 32-wk turkey hens followed by a successively increasing population of these cells up to the 38th week of bird's life. The results of our study have also shown a similar dependency between birds' age and number of B lymphocytes. In addition, we demonstrated a decrease in the number of immune system cells in the oviduct, blood, and spleen of turkey hens in the late and end laying period. The differences reported in the number of lymphocyte subpopulations in the reproductive system of laying turkey hens at various stages of the production cycle may, to some extent, explain the frequency and periods of increased predilection to the incidence of infectious diseases in birds under field conditions.Entities:
Keywords: flow cytometry; lymphocyte; oviduct; turkey hen
Year: 2020 PMID: 32475436 PMCID: PMC7597681 DOI: 10.1016/j.psj.2020.03.005
Source DB: PubMed Journal: Poult Sci ISSN: 0032-5791 Impact factor: 3.352
Percentages of T and B cell subpopulations1 in blood and spleen of breeder turkey hens at 5 different time points (sampling 1–32nd wk of birds' life, 2–38th wk, 3—44th wk, 4—50th wk, and 5–56th wk).
| Blood samples | Sampling time | ||||
|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | |
| T cell subpopulations | |||||
| CD4+ | 10.52a | 11.11a | 11.26a | 15.89a | 8.01a |
| CD8+ | 2.48a | 3.27a | 4.81a | 4.30a | 2.49a |
| CD4+ CD8+ | 0.3b | 0.94a | 0.56a,b | 0.72a,b | 0.64a,b |
| B cell population | |||||
| IgM+ | 4.51b | 4.69b | 4.39b | 5.95a,b | 7.10a |
| Spleen samples | |||||
| T cell subpopulations | |||||
| CD4+ | 22.24a,b | 28.54a | 24.92a | 25.84a | 14.65b |
| CD8+ | 46.44a | 38.16a,b,c | 39.88a,b | 32.48b,c | 27.4c |
| CD4+ CD8+ | 2.57a | 4.06a | 2.47a | 2.21a | 2.16a |
| B cell population | |||||
| IgM+ | 8.66b | 11.88a,b | 12.62a | 12.30a | 9,08b |
a-cMean values in a line for equal samples with different superscript letters are significantly different (Tukey's test, P < 0,05).
Measured by flow cytometry (see the Materials and Methods section).
Mean ACC (±SD) of T and B cell subpopulations1 in oviductal mucosa of breeder turkey hens at 5 different time points (sampling 1–32nd wk of birds' life, 2–38th wk, 3–44th wk, 4–50th wk, and 5–56th wk).
| Part of oviduct | Section | Cells subpopulation | Sampling time | ||||
|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | |||
| Magnum | MI | CD4+ | 40,462.2b ± 37,868.1 | 19,0232.5b ± 91,988.2 | 329,290a ± 192,847.2 | 166,450b ± 75,401.91 | 111,542b ± 56,987.52 |
| CD8+ | 72,354.2b ± 68,312.7 | 18,3622.5a,b ± 78,645.1 | 327,586a ± 244,828.1 | 157,848a,b ± 52,518.4 | 98,350b ± 65,831.1 | ||
| CD4+ CD8+ | 5,499.6a ± 6,765.2 | 11,249.5a ± 3,019.8 | 7,913.6a ± 4,020.5 | 13,789.8a ± 8,360.5 | 6,039.4a ± 2,886.3 | ||
| IgM+ | 13,708.6b ± 12,198.9 | 53,084.5a,b ± 29,946.8 | 95,956.8a ± 60,272.2 | 36,902.6b ± 13,890.3 | 28,867b ± 20,930.5 | ||
| MM | CD4+ | 48,825.6a ± 38,944.7 | 125,315a ± 27,898.3 | 213,602a ± 15,930.6 | 190,326a ± 174,357.9 | 103,290a ± 102,670.5 | |
| CD8+ | 164489,2a ± 130,997 | 161,697a ± 37,772.7 | 267,946a ± 53,074.3 | 219,784a ± 143,939 | 107,188a ± 115,634 | ||
| CD4+ CD8+ | 6,910.3a ± 6,315.4 | 7,492.7a ± 2,644.7 | 11,454.6a ± 4,343.9 | 17,581.4a ± 16,097.2 | 8,452.6a ± 9,394 | ||
| IgM+ | 20,665.9b ± 15,271.8 | 51,656a,b ± 15,621.9 | 79,943.2a ± 14,542.7 | 50,108a,b ± 41,162.3 | 30,343.6a,b ± 31,439.7 | ||
| MF | CD4+ | 28,638b ± 22,643.3 | 82,595b ± 20,918.8 | 242,074a ± 90,638.2 | 120,672a,b ± 70,329.7 | 125,938a,b ± 43,877.6 | |
| CD8+ | 69,260.6b ± 65,312.5 | 180,360a,b ± 35,483.5 | 321,892a ± 189,379.4 | 126,538a,b ± 74,396.1 | 109,516a,b ± 20,045.4 | ||
| CD4+ CD8+ | 4,699.8a ± 6,718.4 | 7,712.5a ± 2,203.2 | 12,783.8a ± 4,784.6 | 12,363.4a ± 10,569 | 10,179a ± 4,120.1 | ||
| IgM+ | 12,868.7b ± 10,044 | 38,586.2b ± 7,575.9 | 110,552.6a ± 63,671.7 | 30,555.2b ± 14,083.1 | 35,425a,b ± 6,896.6 | ||
| Isthmus | CD4+ | 43,770.4a ± 25,272 | 137,085a ± 74,994.7 | 166,284a ± 98,005.5 | 154,712a ± 108,884.7 | 97,230a ± 11,462 | |
| CD8+ | 211,000a ± 190,065.7 | 501,260a ± 394,200.7 | 633,970a ± 342,546.2 | 19,588a ± 97,624.1 | 159,972a ± 5,890 | ||
| CD4+ CD8+ | 12,130.6a ± 11,637.6 | 32,593a ± 10,231.1 | 26,448.4a ± 9,359.9 | 24,488.4a ± 27,295.7 | 15,555.4a ± 2,079.2 | ||
| IgM+ | 25,370a ± 24,647.7 | 92,650.2a ± 61,052.9 | 92,185.8a ± 42,577.7 | 47,790a ± 36,996.8 | 45,634.8a ± 3,440.1 | ||
| Uterus | UI | CD4+ | 79,048b ± 73,037.9 | 268,400a,b ± 204,968.7 | 523,776a ± 251,701.4 | 216,354a,b ± 81,228.2 | 190,850a,b ± 172,853.8 |
| CD8+ | 231,564.2a ± 237,443.5 | 292,050a ± 153,701.2 | 564,616a ± 390,492.5 | 212,928a ± 45,403.7 | 281,162a ± 137,909.9 | ||
| CD4+ CD8+ | 10,178.3a ± 13,259.7 | 15,546.2a ± 13,826.4 | 26,716.6a ± 11,235.4 | 23,596.2a ± 14,143.9 | 21,291.8a ± 15,070 | ||
| IgM+ | 23,123.7b ± 18,844.6 | 87,712a,b ± 48,426.6 | 145,226.8a ± 67,345.1 | 49,525b ± 15,673.9 | 61,439.6a,b ± 42,021.8 | ||
| UM | CD4+ | 42,957.2b ± 55,787.7 | 206,560a,b ± 65,534.5 | 315,206a ± 39,340.2 | 192,846a,b ± 104,027.7 | 136,828.8a,b ± 122,138.8 | |
| CD8+ | 141,307.4a ± 220,472.1 | 229,665a ± 159,756.8 | 344,350a ± 177,754.1 | 160,334a ± 62,560.9 | 232,456a ± 120,043.9 | ||
| CD4+ CD8+ | 7,823.4a ± 12,469.6 | 10,523.2a ± 7,741.2 | 19,760.6a ± 10,413.1 | 19,360.4a ± 14,674.6 | 14,523.6a ± 10,414.3 | ||
| IgM+ | 17,476.8b ± 24,264 | 65,421.2a,b ± 20,779.8 | 89,947a ± 20,844.5 | 41,012.4a,b ± 21,088.3 | 47,990.4a,b ± 27,572.2 | ||
| UF | CD4+ | 39,676.2c ± 37,257.2 | 175,677.5a,b ± 60,152.12 | 291,364a ± 103,108.9 | 165,554a,b ± 61,122.6 | 83,589b,c ± 40,212.8 | |
| CD8+ | 147,949a ± 209,412.5 | 267,170a ± 177,607 | 305,388a ± 179,660.3 | 152,196a ± 47,694.2 | 196,852a ± 182,473.2 | ||
| CD4+ CD8+ | 6,926.8a ± 10,845 | 10,143a ± 4,783.5 | 16,340a ± 4,349.1 | 15,424.2a ± 8,812.9 | 10,909.6a ± 7,596.8 | ||
| IgM+ | 15,632.5b ± 14,036.7 | 77,430.2a ± 38,894.4 | 80,674.2a ± 36,101.6 | 37,564.8a,b ± 11,266.6 | 34,396a,b ± 24,023.2 | ||
a-cMean values in a line for equal samples with different superscript letters are significantly different (Tukey's test, P < 0.05).
Abbreviations: MF, final section of magnum; MI, initial section of magnum; MM, middle section of magnum; UF, final section of uterus; UI, initial section of uterus; UM, middle section of uterus.
Measured by flow cytometry (see the Materials and Methods section).